The Pasadena site activities focus on formulation, filling and packaging of consumer use pesticide products. The site hosts multiple liquid and dust filling production lines.
“This will give us the agility and capacity required to meet our aggressive growth ambitions for the U.S. market,” said Jim Van Handel, President of SBM, N.A. “It marks another strategic step in our North American expansion plans.”
The projected sale of the site to SBM is expected to close in late 2017.
ALSO READ: Monsanto shareholders approve Bayer merger
The $57 billion deal is expected to close by the end of 2017.
Photo: Courtesy of Bayer